Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 279 of 1,261
  1. US 11267896

    Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  2. US 11268065

    Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

    Precision BioSciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  3. US 11266488

    Tissue repair fiber membrane, preparation method and application thereof, and tissue repair product

    Medprin Regenerative Medical Technologies Co., Ltd. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  4. US 11267845

    Inhibitors of CD73-mediated immunosuppression

    Arcus Biosciences, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  5. US 11266611

    More potent and less toxic formulations of epinephrine and methods of medical use

    Eton Pharmaceuticals, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  6. US 11267812

    KRAS G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  7. US 2022062444

    PHARMACEUTICAL COMPOSITIONS COMPRISING GD-COMPLEXES AND POLYARYLENE ADDITIVES

    BRACCO IMAGING SPA [IT] · Granted Mar 3, 2022 · Expires Feb 26, 2042

    granted
  8. WO 2022043557

    MÉTHODE DE TRAITEMENT DE CANCERS EXPRIMANT LE PSMA

    ADVANCED ACCELERATOR APPLICATIONS INT SA [CH] · Granted Mar 3, 2022 · Expires Feb 26, 2042

    granted
  9. WO 2022043558

    MÉTHODE DE TRAITEMENT DE CANCERS EXPRIMANT LE PSMA

    ADVANCED ACCELERATOR APPLICATIONS INT SA [CH] · Granted Mar 3, 2022 · Expires Feb 26, 2042

    granted
  10. US 11260058

    Compositions and method of treating cancer

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  11. US 11261197

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  12. US 11260185

    Pressurized metered dose inhalers and method of manufacture

    Cardiff Scintigraphics Limited · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  13. US 11261447

    Methods for inhibition of HAO1 (hydroxyacid oxidase 1 (glycolate oxidase)) gene expression

    Alnylam Pharmaceuticals, Inc. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  14. US 11260083

    Compositions and methods for treating and preventing graft versus host disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  15. US 11261237

    Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  16. US 11261471

    Methods and compositions for making vault particles in yeast

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  17. US 11261461

    Methods and compositions for selective generation of dopaminergic precursors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  18. US 11261444

    Organic compositions to treat EPAS1-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  19. US 11261432

    Method and composition for inducing human pluripotent stem cells

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  20. US 11261231

    Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors

    The Regents of the University of California · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  21. US 11261248

    Restricted immunoglobulin heavy chain mice

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  22. US 11261230

    Synthetic somatostatin receptor ligands

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  23. US 11261214

    Bicyclic peptide ligand specific for CD137

    BicycleTx Limited · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted
  24. US 11261190

    Dihydropyrimidine compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Mar 1, 2022 · Expires Feb 24, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.